#6021 on the rich list of 14,644 insiders
Blake Borgeson
Director at Recursion Pharmaceuticals. Based in Salt Lake City, Utah.
$16.4M
in disclosed stock, −$789K (−4.60%) today
Live prices, last trade 3:08 PM ET
- Rank
- 6021st of 14,644
- Companies held
- 1
- Largest holding
- RXRX, 100.0% of total
- Latest SEC filing
- Nov 3, 2026
What the $16.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals RXRX Class A Common Stock | Directly | 6,068,287 | $2.70 | $16.4M | 100.0% | Form 4, Nov 3, 2026 |
Share counts are the amounts Blake Borgeson reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Sold | RXRX | 40,000 | $3.88 | $155K | View |
| Oct 6, 2026 | Sold | RXRX | 50,000 | $4.84 | $242K | View |
| Sep 1, 2026 | Sold | RXRX | 30,000 | $3.34 | $100K | View |
| Aug 4, 2026 | Sold | RXRX | 30,000 | $3.25 | $98K | View |
| Jul 7, 2026 | Sold | RXRX | 40,000 | $3.96 | $158K | View |
| Jun 2, 2026 | Sold | RXRX | 30,000 | $3.68 | $110K | View |
| May 5, 2026 | Sold | RXRX | 30,000 | $3.52 | $106K | View |
| Apr 7, 2026 | Sold | RXRX | 30,000 | $3.10 | $93K | View |
| Mar 3, 2026 | Sold | RXRX | 170,000 | $3.46 | $588K | View |
| Feb 3, 2026 | Sold | RXRX | 220,000 | $4.20 | $924K | View |
| Jan 6, 2026 | Sold | RXRX | 220,000 | $4.36 | $959K | View |
| Dec 2, 2025 | Sold | RXRX | 220,000 | $4.37 | $961K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6018 | Michael Nierenberg Chief Executive Officer, Rithm Capital. New York, NY | $16.4M |
| 6019 | Christopher E French Executive Chairman, Shenandoah Telecommunications. Edinburg, VA | $16.4M |
| 6020 | James M. Whitehurst Director, Unity Software. San Francisco, CA | $16.4M |
| 6021 | Blake Borgeson Director, Recursion Pharmaceuticals. Salt Lake City, UT | $16.4M |
| 6022 | Henry Elkus Director, Energy Vault Holdings. Westlake Village, CA | $16.3M |
| 6023 | Melanie Susan Cibik EVP, GenCounsel, CCO & Sec., Teledyne Technologies. Thousand Oaks,, CA | $16.3M |
| 6024 | Michael S. Weinbach Sr. Executive Vice President, Wells Fargo &. Wayne, PA | $16.3M |
Other Recursion Pharmaceuticals insiders
All RXRX insiders- Christopher Gibson$16.4MDirector. #5969 overall
- Dean Y. Li$9.3MDirector. #4862 overall
- Najat Khan$5.4MCEO and President. #13805 overall
- Michael Secora$4.0MChief Financial Officer. #10364 overall
- Fred Hassan$422KDirector. #9328 overall
Questions
How much stock does Blake Borgeson own?
Blake Borgeson holds $16,354,033 in listed stock based on SEC filings and current prices, mostly Recursion Pharmaceuticals (RXRX). That ranks 6021st on the Stock Rich List.
Is this Blake Borgeson's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Blake Borgeson last buy or sell stock?
The most recent open-market trade on file is a sale of 40,000 RXRX shares on Nov 3, 2026 at $3.88.